Dun LiangExecutive Director, Diagnostics Regulatory Strategy at Loxo@LillySpeaker
Agenda Sessions
A Pharma Perspective: Managing a Broad Drug Development and CDx Portfolio in the Current State of IVD Regulations
, 16:30View SessionIVDs, Innovation and Industry: How Are We Shaping Up?
, 08:55View Session